Avrobio Stock Fundamentals

AVRODelisted Stock  USD 1.40  0.04  2.78%   
AVROBIO fundamentals help investors to digest information that contributes to AVROBIO's financial success or failures. It also enables traders to predict the movement of AVROBIO Stock. The fundamental analysis module provides a way to measure AVROBIO's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AVROBIO stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AVROBIO Company Shares Owned By Insiders Analysis

AVROBIO's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Insiders Shares

 = 

Executives Shares

+

Employees

More About Shares Owned By Insiders | All Equity Analysis

Current AVROBIO Shares Owned By Insiders

    
  1.65 %  
Most of AVROBIO's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AVROBIO is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Competition

Based on the latest financial disclosure, 1.65% of AVROBIO are shares owned by insiders. This is 89.13% lower than that of the Biotechnology sector and 88.36% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 83.65% higher than that of the company.

AVROBIO Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AVROBIO's current stock value. Our valuation model uses many indicators to compare AVROBIO value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AVROBIO competition to find correlations between indicators driving AVROBIO's intrinsic value. More Info.
AVROBIO is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AVROBIO's earnings, one of the primary drivers of an investment's value.

AVROBIO Shares Owned By Insiders Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AVROBIO's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AVROBIO could also be used in its relative valuation, which is a method of valuing AVROBIO by comparing valuation metrics of similar companies.
AVROBIO is currently under evaluation in shares owned by insiders category among its peers.

AVROBIO Fundamentals

About AVROBIO Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AVROBIO's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AVROBIO using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AVROBIO based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Avrobio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 122 people.

Pair Trading with AVROBIO

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AVROBIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AVROBIO will appreciate offsetting losses from the drop in the long position's value.

Moving against AVROBIO Stock

  0.87HYMTF Hyundai MotorPairCorr
  0.84MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.81TLK Telkom Indonesia TbkPairCorr
  0.77EC Ecopetrol SA ADRPairCorr
  0.75SHG Shinhan FinancialPairCorr
The ability to find closely correlated positions to AVROBIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AVROBIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AVROBIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AVROBIO to buy it.
The correlation of AVROBIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AVROBIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AVROBIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AVROBIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Consideration for investing in AVROBIO Stock

If you are still planning to invest in AVROBIO check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AVROBIO's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals